Enteral Syringes

Global Enteral Syringes Market to Reach US$2.2 Billion by 2030

The global market for Enteral Syringes estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Disposable, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Reusable segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$412.5 Million While China is Forecast to Grow at 9.0% CAGR

The Enteral Syringes market in the U.S. is estimated at US$412.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$525.9 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Enteral Syringes Market - Key Trends and Drivers Summarized

What Are Enteral Syringes and Why Are They Essential?

Enteral syringes are specialized medical devices used for administering liquid nutrition, medications, and fluids directly into the gastrointestinal (GI) tract of patients who cannot ingest food or drugs orally. Unlike standard syringes, enteral syringes are specifically designed to ensure compatibility with enteral feeding systems, minimizing the risk of dangerous misconnections with intravenous or other medical tubing. They are primarily used in both hospital and homecare settings for delivering precise doses of medications, flushing feeding tubes, or administering bolus nutrition directly through a feeding tube. Enteral syringes come in various sizes, typically ranging from 1 mL to 60 mL, to accommodate different patient needs and feeding protocols. These syringes are available in single-use and reusable formats, each serving distinct purposes: single-use syringes are intended to reduce cross-contamination risks in critical care settings, while reusable options are popular in homecare due to their cost-effectiveness. Due to their critical role in enteral feeding and medication administration, enteral syringes must adhere to stringent safety regulations and standards, including color-coded designs and unique connector types to distinguish them from other delivery systems. These safety features are integral to preventing adverse events such as enteral misconnections, which have historically been a significant concern in medical practice.

How Are Technological Advancements Shaping Enteral Syringe Design?

Technological innovations have led to substantial improvements in enteral syringe design and functionality, making them safer and more user-friendly for both healthcare professionals and caregivers. One of the most notable advancements is the introduction of the ENFit® connector, a globally recognized standard developed as part of the ISO 80369-3 regulations. This connector is designed to prevent cross-connections between enteral and non-enteral systems, addressing a major patient safety issue by ensuring that enteral syringes cannot be mistakenly attached to intravenous lines. Additionally, enteral syringes are now manufactured with clear gradation markings, ergonomic designs for better handling, and non-latex materials to accommodate patients with allergies. The use of advanced plastics and polymers has also improved the durability and sterility of syringes, enhancing their reliability in critical care applications. Some modern syringes come with safety caps and tamper-proof seals, further reducing the risk of contamination and medication errors. Another technological trend is the integration of smart technology in enteral syringe pumps, which enables precise control over fluid delivery rates and volumes. These pumps often include digital interfaces and alarm systems to alert caregivers if there are blockages or disconnections in the feeding line. Collectively, these advancements are revolutionizing the way enteral syringes are utilized, offering heightened safety and efficiency, and enabling more accurate enteral medication and nutrition delivery.

Which Patient Groups Rely on Enteral Syringes the Most?

Enteral syringes are indispensable for a wide array of patient groups, particularly those with complex nutritional and medication administration needs. Pediatric patients often require enteral syringes for bolus feeding, as well as for administering medications that cannot be safely ingested orally due to risks of aspiration or difficulty swallowing. Children with conditions such as cerebral palsy, cleft palate, or severe gastroesophageal reflux disease (GERD) rely on enteral syringes for feeding and drug administration to ensure adequate growth and development. Similarly, critically ill adults in intensive care units (ICUs) often depend on enteral syringes for delivering medications and nutritional supplements directly through their feeding tubes. Enteral syringes are also crucial for elderly patients with dysphagia (difficulty swallowing) or neurodegenerative conditions like Parkinson’s disease and Alzheimer’s, where oral feeding is either unsafe or ineffective. Beyond the hospital environment, patients in long-term care facilities and homecare settings frequently use enteral syringes for ongoing nutritional and medication management. For these patients, the ease of use, clear labeling, and safety features of modern enteral syringes play a pivotal role in ensuring adherence to feeding and medication regimens. Thus, enteral syringes are a vital tool in the continuum of care, supporting the safe and effective administration of essential nutrients and pharmaceuticals across diverse patient demographics.

What Factors Are Driving the Growth of the Enteral Syringe Market?

The growth in the enteral syringe market is driven by several factors, including the increasing prevalence of chronic diseases, the aging population, and stringent safety regulations promoting the use of ENFit®-compatible devices. One of the primary growth drivers is the rising incidence of conditions like cancer, neurological disorders, and gastrointestinal diseases, which often require long-term enteral nutrition and medication management. This, coupled with the expanding geriatric population that is more susceptible to malnutrition and swallowing difficulties, has increased the demand for enteral syringes in both clinical and homecare settings. Technological advancements, such as the adoption of the ENFit® standard, have further fueled market expansion by ensuring higher safety standards and reducing the risk of misconnections, which historically posed significant patient safety concerns. The transition to ENFit®-compliant products has created a surge in demand as healthcare facilities update their inventory to comply with these new regulations. Another growth driver is the rising preference for home-based enteral care, driven by the need to reduce healthcare costs and improve patient comfort. This trend has led to a higher uptake of user-friendly enteral syringes that caregivers can easily manage at home, creating a new market segment for manufacturers. Additionally, increasing healthcare expenditure, particularly in emerging markets, and the rising awareness of enteral feeding safety protocols are supporting the adoption of enteral syringes worldwide. As the demand for personalized and patient-specific enteral solutions grows, the enteral syringe market is set to see sustained expansion, driven by a confluence of safety regulations, technological innovation, and evolving patient care trends.

SCOPE OF STUDY:

The report analyzes the Enteral Syringes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Disposable, Reusable); Application (Cancer, Malnutrition, Neurological Disease, GI Related Disease, Other Applications); End-Use (Hospitals & Ambulatory Care Centers, Home-based Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• B. Braun Melsungen AG
• Baxter International, Inc.
• Cardinal Health, Inc.
• GBUK Enteral Ltd.
• Kentec Medical, Inc.
• Koninklijke Philips N.V.
• Medela LLC
• Miktell Ltd.
• NeoMed, Inc.
• Terumo Corporation
• Vygon S.A.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs CBob geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.